The Journal of Biomedical and Clinical Research (JBCR), the peer-reviewed, multidisciplinary scientific journal of Medical University Pleven, has moved to Pensoft’s ARPHA platform. Enjoying an improved publishing infrastructure, the journal has already published its first issue after the move on its new ARPHA-powered website.
Open to scientists from all fields of medicine and related areas, JBCR welcomes interdisciplinary scientific results and articles presenting diverse pathologies from various clinical perspectives. It publishes reviews, original articles, and communications relevant to biomedical, clinical, and public health, medical education, and case reports.
Published since 2008, JBCR is a diamond open-access journal, meaning it requires no article submission charges, and is free to both authors and readers. The journal currently publishes two issues per year.
Opting for ARPHA’s white-label solution, JBCR joins a number of academic journals in medicine already hosted on the ARPHA platform, such as Folia Medica and Pharmacia. It will take advantage of ARPHA’s signature fast-track publishing system, which offers an end-to-end solution from submission to publication, distribution and archiving. By leveraging the innovative platform, JBCR enhances the visibility and impact of the published research, providing a better experience for its authors, readers, and editors.
"We are excited to welcome the Journal of Biomedical and Clinical Research to ARPHA’s family of next-generation scientific journals," said Lyubomir Penev, CEO and founder of Pensoft, the company behind the ARPHA platform. "With the help of ARPHA's publishing solutions, JBCR can ensure efficient, high-quality dissemination of important medical research."